Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...

Discover the future of data storage and computing with DNA technology, revolutionizing information technology as we know it.

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), ...

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

A biotech company has announced plans to acquire 23andMe after the genetic testing company filed for Chapter 11 bankruptcy.

Regeneron is buying 23andMe for $256M in bankruptcy, gaining access to DNA data from 15 million users to aid drug research.

Biotechnology company Regeneron Pharmaceuticals ... and build upon its mission to help people learn about their own DNA and how to improve their personal health, while furthering Regeneron's ...